+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Hot Flashes - Pipeline Insight, 2025 - Product Thumbnail Image

Hot Flashes - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Emphysema - Pipeline Insight, 2025 - Product Thumbnail Image

Emphysema - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Retinitis Pigmentosa- Pipeline Insight, 2025 - Product Thumbnail Image

Retinitis Pigmentosa- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 150 Pages
  • Global
From
Nosocomial Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Nosocomial Infections - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Nocturia - Pipeline Insight, 2025 - Product Thumbnail Image

Nocturia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Nicotine Addiction - Pipeline Insight, 2025 - Product Thumbnail Image

Nicotine Addiction - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Neurofibromatoses - Pipeline Insight, 2025 - Product Thumbnail Image

Neurofibromatoses - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Juvenile Rheumatoid Arthritis - Pipeline Insight, 2025 - Product Thumbnail Image

Juvenile Rheumatoid Arthritis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Hyperphosphatemia - Pipeline Insight, 2025 - Product Thumbnail Image

Hyperphosphatemia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Hyperparathyroidism - Pipeline Insight, 2025 - Product Thumbnail Image

Hyperparathyroidism - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Hyperoxaluria - Pipeline Insight, 2025 - Product Thumbnail Image

Hyperoxaluria - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Hyperkalemia - Pipeline Insight, 2025 - Product Thumbnail Image

Hyperkalemia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Gastroparesis - Pipeline Insight, 2025 - Product Thumbnail Image

Gastroparesis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Urea Cycle Disorders - Pipeline Insight, 2025 - Product Thumbnail Image

Urea Cycle Disorders - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Typhoid Fever - Pipeline Insight, 2025 - Product Thumbnail Image

Typhoid Fever - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Traveler's Diarrhea - Pipeline Insight, 2025 - Product Thumbnail Image

Traveler's Diarrhea - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Thrombotic Thrombocytopenic Purpura - Pipeline Insight, 2025 - Product Thumbnail Image

Thrombotic Thrombocytopenic Purpura - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Pleural Effusion - Pipeline Insight, 2025 - Product Thumbnail Image

Pleural Effusion - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Plague - Pipeline Insight, 2025 - Product Thumbnail Image

Plague - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more